Cargando…

A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid

BACKGROUND: Avidity determination of antigen-specific immunoglobulin G (IgG) antibodies is an established serological method to differentiate acute from past infections. In order to compare the avidity of varicella-zoster virus (VZV) IgG in pairs of serum and cerebrospinal fluid (CSF) samples, we de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kneitz, Ralf-Herbert, Schubert, Jörg, Tollmann, Franz, Zens, Wolfgang, Hedman, Klaus, Weissbrich, Benedikt
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522815/
https://www.ncbi.nlm.nih.gov/pubmed/15355548
http://dx.doi.org/10.1186/1471-2334-4-33
_version_ 1782121853240737792
author Kneitz, Ralf-Herbert
Schubert, Jörg
Tollmann, Franz
Zens, Wolfgang
Hedman, Klaus
Weissbrich, Benedikt
author_facet Kneitz, Ralf-Herbert
Schubert, Jörg
Tollmann, Franz
Zens, Wolfgang
Hedman, Klaus
Weissbrich, Benedikt
author_sort Kneitz, Ralf-Herbert
collection PubMed
description BACKGROUND: Avidity determination of antigen-specific immunoglobulin G (IgG) antibodies is an established serological method to differentiate acute from past infections. In order to compare the avidity of varicella-zoster virus (VZV) IgG in pairs of serum and cerebrospinal fluid (CSF) samples, we developed a new technique of avidity testing, the results of which are not influenced by the concentration of specific IgG. METHODS: The modifications introduced for the new VZV IgG avidity method included the use of urea hydrogen peroxide as denaturing reagent, the adaptation of the assay parameters in order to increase the sensitivity for the detection of low-level VZV IgG in CSF, and the use of a new calculation method for avidity results. The calculation method is based on the observation that the relationship between the absorbance values of the enzyme immunoassays with and without denaturing washing step is linear. From this relationship, a virtual absorbance ratio can be calculated. To evaluate the new method, a panel of serum samples from patients with acute and past VZV infection was tested as well as pairs of serum and CSF. RESULTS: For the serum panel, avidity determination with the modified assay gave results comparable to standard avidity methods. Based on the coefficient of variation, the new calculation method was superior to established methods of avidity calculation. CONCLUSIONS: The new avidity method permits a meaningful comparison of VZV IgG avidity in serum and CSF and should be of general applicability for easy determination of avidity results, which are not affected by the concentration of specific IgG.
format Text
id pubmed-522815
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5228152004-10-17 A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid Kneitz, Ralf-Herbert Schubert, Jörg Tollmann, Franz Zens, Wolfgang Hedman, Klaus Weissbrich, Benedikt BMC Infect Dis Technical Advance BACKGROUND: Avidity determination of antigen-specific immunoglobulin G (IgG) antibodies is an established serological method to differentiate acute from past infections. In order to compare the avidity of varicella-zoster virus (VZV) IgG in pairs of serum and cerebrospinal fluid (CSF) samples, we developed a new technique of avidity testing, the results of which are not influenced by the concentration of specific IgG. METHODS: The modifications introduced for the new VZV IgG avidity method included the use of urea hydrogen peroxide as denaturing reagent, the adaptation of the assay parameters in order to increase the sensitivity for the detection of low-level VZV IgG in CSF, and the use of a new calculation method for avidity results. The calculation method is based on the observation that the relationship between the absorbance values of the enzyme immunoassays with and without denaturing washing step is linear. From this relationship, a virtual absorbance ratio can be calculated. To evaluate the new method, a panel of serum samples from patients with acute and past VZV infection was tested as well as pairs of serum and CSF. RESULTS: For the serum panel, avidity determination with the modified assay gave results comparable to standard avidity methods. Based on the coefficient of variation, the new calculation method was superior to established methods of avidity calculation. CONCLUSIONS: The new avidity method permits a meaningful comparison of VZV IgG avidity in serum and CSF and should be of general applicability for easy determination of avidity results, which are not affected by the concentration of specific IgG. BioMed Central 2004-09-08 /pmc/articles/PMC522815/ /pubmed/15355548 http://dx.doi.org/10.1186/1471-2334-4-33 Text en Copyright © 2004 Kneitz et al; licensee BioMed Central Ltd.
spellingShingle Technical Advance
Kneitz, Ralf-Herbert
Schubert, Jörg
Tollmann, Franz
Zens, Wolfgang
Hedman, Klaus
Weissbrich, Benedikt
A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid
title A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid
title_full A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid
title_fullStr A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid
title_full_unstemmed A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid
title_short A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid
title_sort new method for determination of varicella-zoster virus immunoglobulin g avidity in serum and cerebrospinal fluid
topic Technical Advance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522815/
https://www.ncbi.nlm.nih.gov/pubmed/15355548
http://dx.doi.org/10.1186/1471-2334-4-33
work_keys_str_mv AT kneitzralfherbert anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT schubertjorg anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT tollmannfranz anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT zenswolfgang anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT hedmanklaus anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT weissbrichbenedikt anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT kneitzralfherbert newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT schubertjorg newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT tollmannfranz newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT zenswolfgang newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT hedmanklaus newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid
AT weissbrichbenedikt newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid